AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18094551 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE test with drained urine (D)
Number of subjects: 30
Study 18094551 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE test with irrigated urine (I)
Number of subjects: 30
Study 16134739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training programme for 30 minutes per day for 17 weeks
Number of subjects: 38
Study 16134739 — intervention group
Group type: COMPARATOR
Intervention: Freely chosen interactive activity for 30 minutes per day for 17 weeks
Number of subjects: 38
Study 11846194 — intervention group
Group type: EXPERIMENTAL
Intervention: Single strip application with root planing
Number of subjects: 24
Study 11846194 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple strip application with root planing
Number of subjects: 24
Study 11846194 — intervention group
Group type: COMPARATOR
Intervention: Root planing alone
Number of subjects: 24
Study 11846194 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 24
Study 10628577 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario A (insomnia and poor concentration meeting DSM-III-R criteria for major depressive disorder)
Number of subjects: 149
Study 10628577 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario B (tension headaches meeting criteria for minor depression)
Number of subjects: 149
Study 7536830 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein, high-energy drink
Number of subjects: 4
Study 7536830 — intervention group
Group type: COMPARATOR
Intervention: No-protein, low-energy drink
Number of subjects: 4
Study 7536830 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up study
Number of subjects: 4
Study 12041767 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin (2 or 4 g/day)
Number of subjects: 22
Study 6348425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 0
Study 6348425 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 0
Study 6348425 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Cefazolin and Cefamandole)
Number of subjects: 0
Study 31662372 — intervention group
Group type: EXPERIMENTAL
Intervention: General health checks offered to invitees with follow-up consultations if test results were abnormal.
Number of subjects: 3464
Study 31662372 — intervention group
Group type: COMPARATOR
Intervention: General health checks offered to invitees compared to the external control group (remaining Danish population receiving routine care).
Number of subjects: 3464
Study 30422263 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated electronic clinical decision support system (CDSS) implemented at intervention sites.
Number of subjects: 1703
Study 30422263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CDSS intervention).
Number of subjects: 1703
Study 27549145 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored return to work (RTW) program
Number of subjects: 171
Study 27549145 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study 24126967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based individual counseling (PedIC)
Number of subjects: 195
Study 24126967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based group counseling (PedGC)
Number of subjects: 195
Study 24126967 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 195
Study 24126967 — intervention group
Group type: COMPARATOR
Intervention: Minimal treatment comparator (MTC)
Number of subjects: 195
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond Multi‐Purpose (MP, 3M ESPE)
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Plus (SB, 3M ESPE)
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond SE (SE, 3M ESPE)
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Easy Bond (EB, 3M ESPE)
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: All adhesives
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesives (EB and SE)
Number of subjects: 39
Study 21942235 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Easy Bond (EB)
Number of subjects: 39
Study 21130362 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback therapy (3 weeks duration)
Number of subjects: 36
Study 21130362 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 36
Study 17555385 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced urinary sodium
Number of subjects: 782
Study 17555385 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved fitness
Number of subjects: 782
Study 17555385 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to the DASH diet
Number of subjects: 782
Study 17555385 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness change (with weight included)
Number of subjects: 782
Study 16378069 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac/MMF
Number of subjects: 451
Study 16378069 — intervention group
Group type: EXPERIMENTAL
Intervention: Bas/Tac
Number of subjects: 451
Study 16378069 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 451
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile (probe) and cold air (dental air syringe) stimuli used for clinical evaluation of DH.
Number of subjects: 117
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 117
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal stimulation
Number of subjects: 117
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tactile and thermal stimulation
Number of subjects: 117
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Teeth responding to stimuli
Number of subjects: 117
Study 11896838 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of tactile and thermal/evaporative stimulation
Number of subjects: 117
Study 9648697 — intervention group
Group type: EXPERIMENTAL
Intervention: Bla g 1 (cockroach allergen)
Number of subjects: 40
Study 9648697 — intervention group
Group type: EXPERIMENTAL
Intervention: Bla g 2 (cockroach allergen)
Number of subjects: 40
Study 8005909 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified quiet room (QR) with tea rose walls, carpeted floor, and mural
Number of subjects: 19
Study 8005909 — intervention group
Group type: COMPARATOR
Intervention: Standard quiet room (QR)
Number of subjects: 19
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine (Tetra)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CH)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BAK)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu) + Chlorhexidine (CH)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybuprocaine (OBu) + Benzalkonium chloride (BAK)
Number of subjects: 2
Study 2460291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine (Tetra) + Benzalkonium chloride (BAK)
Number of subjects: 2
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about vaccines recommended for HCWs
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about hepatitis B and influenza vaccines
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for hepatitis B
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for tetanus and pertussis
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for measles/mumps/rubella
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for chickenpox
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization coverage for influenza
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior receipt of all recommended vaccines
Number of subjects: 531
Study 31564452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported immunization likelihood based on age and knowledge
Number of subjects: 531
Study 27634224 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% calorie restricted diet (CR) for 6 months
Number of subjects: 70
Study 27634224 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD) for 6 months
Number of subjects: 70
Study 27634224 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% calorie restricted diet (CR)
Number of subjects: 70
Study 26299380 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led lifestyle counselling sessions
Number of subjects: 71
Study 22860316 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed intervention containing a letter from attending physician, a postcard for decision aid request, and information on obtaining screening.
Number of subjects: 1598
Study 22860316 — intervention group
Group type: COMPARATOR
Intervention: Control group (resident physicians' patients in wave B).
Number of subjects: 1598
Study 22860316 — intervention group
Group type: COMPARATOR
Intervention: Control group (requests for decision aids).
Number of subjects: 1598
Study 20059570 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga lifestyle intervention
Number of subjects: 60
Study 20059570 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment
Number of subjects: 60
Study 18324410 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol and icthammol (G&I) ribbon gauze
Number of subjects: 43
Study 18324410 — intervention group
Group type: COMPARATOR
Intervention: Topical antibiotic and steroid drops
Number of subjects: 43
Study 15954181 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic repositioning method
Number of subjects: 0
Study 15954181 — intervention group
Group type: COMPARATOR
Intervention: Eye method (control)
Number of subjects: 0
Study 11821506 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily hemodialysis
Number of subjects: 160
Study 11821506 — intervention group
Group type: COMPARATOR
Intervention: Conventional (alternate-day) hemodialysis
Number of subjects: 160
Study 10406358 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 0
Study 10406358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8793123 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG mapping with band powers and coherence analysis
Number of subjects: 0
Study 1703746 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-chloramphenicol combination
Number of subjects: 49
Study 1703746 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol alone
Number of subjects: 49
Study 6968705 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-lumen tube incorporating an extra lumen for oesophageal suction
Number of subjects: 28
Study 6968705 — intervention group
Group type: COMPARATOR
Intervention: modified 3-lumen Sengstaken tube
Number of subjects: 28
Study 31581690 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna yoga at moderate temperature (50 °C)
Number of subjects: 23
Study 31581690 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 23
Study 29292040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery cognitive training
Number of subjects: 59
Study 29292040 — intervention group
Group type: EXPERIMENTAL
Intervention: Flashcards cognitive training
Number of subjects: 59
Study 29292040 — intervention group
Group type: COMPARATOR
Intervention: Control (simulation training only)
Number of subjects: 59
Study 27983900 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (group 1, n=20)
Number of subjects: 40
Study 27983900 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider reduction (group 2, n=20)
Number of subjects: 40
Study 27983900 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study 25329201 — intervention group
Group type: EXPERIMENTAL
Intervention: GERA (Genetic and Environmental Risk Assessment)
Number of subjects: 783
Study 25329201 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 783
Study 25329201 — intervention group
Group type: EXPERIMENTAL
Intervention: GERA (within GERA group)
Number of subjects: 783
Study 25329201 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated-risk participants (within GERA group)
Number of subjects: 783
Study 25329201 — intervention group
Group type: EXPERIMENTAL
Intervention: GERA
Number of subjects: 783
Study 23155345 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated carbon nanoparticles suspension (ACNS), 1 mL subserosal injection in a 4-quadrant region around the mass.
Number of subjects: 60
Study 23155345 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB), 2 mL injected into the isolated, stretched and fixed vessel after specimen removal.
Number of subjects: 60
Study 23155345 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-stained conventional surgical group), no ACNS or MB injected.
Number of subjects: 60
Study 23155345 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 60
Study 20036361 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth plan intervention
Number of subjects: 296
Study 20036361 — intervention group
Group type: COMPARATOR
Intervention: Control group (no birth plan)
Number of subjects: 296
Study 18580400 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microg
Number of subjects: 19
Study 18580400 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 800 microg
Number of subjects: 19
Study 18580400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 16483177 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg ganirelix sc daily for 7 days
Number of subjects: 24
Study 16483177 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.250 mg ganirelix sc daily for 7 days
Number of subjects: 24
Study 16483177 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.500 mg ganirelix sc daily for 7 days
Number of subjects: 24
Study 11940273 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 0
Study 11940273 — intervention group
Group type: COMPARATOR
Intervention: Gastric tonometry
Number of subjects: 0
Study 11940273 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 0
Study 11940273 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal membrane oxygenation
Number of subjects: 0
Study 11940273 — intervention group
Group type: COMPARATOR
Intervention: Closed intensive care units
Number of subjects: 0
Study 10601934 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily nonstress test
Number of subjects: 135
Study 10601934 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily biophysical profile
Number of subjects: 135
Study 8848515 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (muscarinic antagonist)
Number of subjects: 0
Study 8848515 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (nicotinic antagonist)
Number of subjects: 0
Study 8848515 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 0
Study 2286929 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective elimination of oral flora
Number of subjects: 15
Study 2286929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2286929 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine rinsing
Number of subjects: 15
Study 7021067 — intervention group
Group type: EXPERIMENTAL
Intervention: racemic epinephrine (RE) nebulized and delivered by manual IPPB
Number of subjects: 14
Study 7021067 — intervention group
Group type: COMPARATOR
Intervention: distilled water nebulized and delivered by manual IPPB
Number of subjects: 14
Study 31284490 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/day anthocyanins (Group A)
Number of subjects: 72
Study 31284490 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg lutein and 2 mg zeaxanthin per day (Group X)
Number of subjects: 72
Study 31284490 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of anthocyanins and xanthophylls (Group A+X)
Number of subjects: 72
Study 31284490 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups (A, X, A+X)
Number of subjects: 72
Study 25884343 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 100
Study 25884343 — intervention group
Group type: COMPARATOR
Intervention: Kyphoplasty
Number of subjects: 100
Study 24389883 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral decubitus, knee-chest position with a 45-degree head-up tilt (group M, n = 100)
Number of subjects: 300
Study 24389883 — intervention group
Group type: COMPARATOR
Intervention: Sitting position (group S, n = 100)
Number of subjects: 300
Study 24389883 — intervention group
Group type: COMPARATOR
Intervention: Lateral decubitus, knee-chest position (group L, n = 100)
Number of subjects: 300
Study 22678961 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense, resistance exercise training (12-week periodized, intensive resistance training)
Number of subjects: 40
Study 22678961 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense, resistance exercise training
Number of subjects: 40
Study 19573972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Operator CPR
Number of subjects: 50
Study 19573972 — intervention group
Group type: COMPARATOR
Intervention: Single Operator CPR
Number of subjects: 50
Study 17855762 — intervention group
Group type: EXPERIMENTAL
Intervention: E45 (90 min of exercise at 45% V(O2)peak)
Number of subjects: 18
Study 17855762 — intervention group
Group type: EXPERIMENTAL
Intervention: E65 (60 min of exercise at 65% V(O2)peak)
Number of subjects: 18
Study 17855762 — intervention group
Group type: EXPERIMENTAL
Intervention: E45
Number of subjects: 18
Study 17855762 — intervention group
Group type: EXPERIMENTAL
Intervention: E45 and E65
Number of subjects: 18
Study 17855762 — intervention group
Group type: COMPARATOR
Intervention: C (sedentary control trial)
Number of subjects: 18
Study 16164885 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, vegan diet
Number of subjects: 64
Study 16164885 — intervention group
Group type: COMPARATOR
Intervention: Control diet (National Cholesterol Education Program guidelines)
Number of subjects: 64
Study 12052850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 12
Study 12052850 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TDN)
Number of subjects: 12
Study 12052850 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (NNS)
Number of subjects: 12
Study 12052850 — intervention group
Group type: COMPARATOR
Intervention: Placebo NNS
Number of subjects: 12
Study 10385777 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg aspirin daily (group A1)
Number of subjects: 285
Study 10385777 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg aspirin on alternate days (group A2)
Number of subjects: 285
Study 10385777 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 285
Study 7759653 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherent frequency modulation (FM) at a rate of 6 Hz and modulation depth of +/‐ 5%.
Number of subjects: 4
Study 7759653 — intervention group
Group type: COMPARATOR
Intervention: No frequency modulation (FM).
Number of subjects: 4
Study 2370089 — intervention group
Group type: EXPERIMENTAL
Intervention: Product of protein/creatinine ratio and estimated daily urinary creatinine excretion
Number of subjects: 40
Study 93179 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-side jejunoileostomy (bypass)
Number of subjects: 196
Study 93179 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment (control)
Number of subjects: 196
Study 30636726 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching protocol (group A)
Number of subjects: 18
Study 30636726 — intervention group
Group type: COMPARATOR
Intervention: No-stretching (group B)
Number of subjects: 18
Study 27131792 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 176
Study 27131792 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 176
Study 27131792 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 176
Study 26030032 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine-based hypotensive anaesthesia
Number of subjects: 47
Study 26030032 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil-based hypotensive anaesthesia
Number of subjects: 47
Study 23999452 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin glargine titrated to a fasting glucose of ≤ 5.3 mmol/L (95 mg/dL)
Number of subjects: 12537
Study 23999452 — intervention group
Group type: COMPARATOR
Intervention: Standard glycaemic care
Number of subjects: 12537
Study 23999452 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycaemia
Number of subjects: 12537
Study 23999452 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe nocturnal hypoglycaemia
Number of subjects: 12537
Study 23999452 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 12537
Study 21895365 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehension of referential pointing at 9 months
Number of subjects: 88
Study 21895365 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehension of an imperative motive at 12 months
Number of subjects: 88
Study 18810661 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirilazad
Number of subjects: 3797
Study 16781788 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor (1 g/day)
Number of subjects: 35
Study 16781788 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 35
Study 15347469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus HRT
Number of subjects: 54